At Novo Nordisk, we are committed to having a supplier base that represents the diverse patients who depend on us every day. We believe that by partnering with diverse suppliers who share our commitment to diversity, equity, inclusion and belonging (DEI&B), we gain an innovative perspective that enables us to strengthen our relationships and support the communities in which we operate as well as ultimately better support our patients.
Novo Nordisk was one of six nominees for the recently announced 2022 Diversity Alliance for Science, Corporate Award. We are proud of our recognition.
Since beginning our Supplier Diversity program, we’ve helped grow diverse suppliers in multiple ways – by awarding business, through mentoring and, offering development opportunities. Today, small and diverse suppliers – comprising minority-owned, Black-owned, Veteran, Service-disabled veteran-owned, HUB zone, 8A and women-owned, to name a few – make up nearly 35% of our in-scope supplier base. We continue to expand our small and diverse base and are constantly in search of meritorious suppliers. We strongly encourage you to register with us.